Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 4 Thyroid Cancer, Papillary 2 Neuroendocrine Tumors 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Pituitary Diseases 1 Pheochromocytoma 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Lymphatic Metastasis 1 Insulinoma 1 Infertility 1 Extranodal Extension 1 Esthesioneuroblastoma, Olfactory 1 Adrenal Gland Neoplasms 1 Adenocarcinoma, Follicular 1 Acromegaly 1

Interventions

fluorodopa F 18 4 Octreotide 4 Everolimus 4 Capecitabine 4 Temozolomide 3 Leucovorin 3 vatalanib 2 Trastuzumab 2 Oxaliplatin 2 Fluorouracil 2 Bortezomib 2 Bevacizumab 2 68Ga-NOTA-exendin-4 2 veliparib 1 tipifarnib 1 romidepsin 1 regorafenib 1 pentetreotide 1 pazopanib 1 pasireotide 1 motesanib diphosphate 1 cixutumumab 1 batifiban 1 Thalidomide 1 Surgical Procedures, Operative 1 Streptozocin 1 Sorafenib 1 Solutions 1 Salts 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Insulinoma × Surgical Procedures, Operative × Endocrine × Clear all

NCT05735912 2026-01-13

ERASIN-RCT

Azienda Ospedaliera Universitaria Integrata Verona

Phase NA Active not recruiting

Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡